[HTML][HTML] GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

X Ma, Z Liu, I Ilyas, PJ Little, D Kamato… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD),
including atherosclerosis, hypertension and heart failure. Some anti-diabetic medications …

Prospective therapeutics for intestinal and hepatic fibrosis

X Li, M Yu, Q Zhao, Y Yu - Bioengineering & translational …, 2023 - Wiley Online Library
Currently, there are no effective therapies for intestinal and hepatic fibrosis representing a
considerable unmet need. Breakthroughs in pathogenesis have accelerated the …

LncLocation: efficient subcellular location prediction of long non-coding RNA-based multi-source heterogeneous feature fusion

S Feng, Y Liang, W Du, W Lv, Y Li - International Journal of Molecular …, 2020 - mdpi.com
Recent studies uncover that subcellular location of long non-coding RNAs (lncRNAs) can
provide significant information on its function. Due to the lack of experimental data, the …

N-acetylcysteine (NAC) alleviates the peripheral neuropathy associated with liver cirrhosis via modulation of neural MEG3/PAR2/NF-ҡB axis

DI Mohamed, E Khairy, SA Khedr, EK Habib… - Neurochemistry …, 2020 - Elsevier
Background and aim Oxidative stress (OS) is accused in pathogenesis of many diseases,
including liver cirrhosis by many mechanisms. One of them is the disturbance of long non …

应用超声心动图评估肝硬化患者心脏结构和功能临床价值研究

胡星, 孟繁坤, 韩晶, 张旭辉 - 实用肝脏病杂志, 2020 - manu43.magtech.com.cn
目的应用超声心动图检测肝硬化患者心脏相关参数, 探讨患者心脏结构和功能的改变及其与终
末期肝病严重程度的相关性. 方法2018 年4 月~ 2019 年4 月我院诊治的124 例肝硬化患者(41 …